Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles

LEADS BIOLABS-B (09887) Core Product Vilixin Granted Orphan Drug Designation in Japan
.png)
PARKSON GROUP (03368) entered into a lease agreement for the property located at Zijin Plaza, Mianyang City.

Policy bottom + valuation rebound, has the real estate industry reached a turning point?
LEADS BIOLABS-B (09887) Core Product Vilixin Granted Orphan Drug Designation in Japan

PARKSON GROUP (03368) entered into a lease agreement for the property located at Zijin Plaza, Mianyang City.
.png)
Policy bottom + valuation rebound, has the real estate industry reached a turning point?






